Literature DB >> 23183439

Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria.

Huanyu Wang1, Andrew L Schwaderer, Jennifer Kline, John David Spencer, David Kline, David S Hains.   

Abstract

Ribonuclease 7 (RNase 7) is a 14.5-kDa peptide that possesses potent antimicrobial properties against Gram-negative and Gram-positive bacteria and is expressed in a variety of epithelial tissues. Little is known about its mechanisms of action and the determinants of its antimicrobial properties. The objective of this study was to identify the intrinsic functional domains of RNase 7 that influence its activity against uropathogenic bacteria. A series of RNase 7 fragments were generated that contained different components of its secondary motifs starting from both the N terminus and the C terminus of RNase 7. We determined the antimicrobial properties of each fragment against both Gram-positive Staphylococcus saprophyticus and Gram-negative Escherichia coli and Proteus mirabilis. RNase 7 fragments displayed significant differences in their antimicrobial activity profiles. Compared to N-terminal fragments, C-terminal fragments showed uniformly decreased activity against Gram-negative E. coli and P. mirabilis and Gram-positive S. saprophyticus. Fragments that lack β-sheets 1, 3, and 4 also demonstrated significantly decreased activities. We have also identified one fragment with at least 4-fold increased potency against both E. coli and Staphylococcus compared to full-length peptide. We identified distinct regions of the peptide that are independently responsible for Gram-negative and Gram-positive activity. Our results suggest that distinct mechanisms are responsible for RNase 7's antimicrobial activity against various uropathogens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183439      PMCID: PMC3553692          DOI: 10.1128/AAC.01378-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  EMBOSS: the European Molecular Biology Open Software Suite.

Authors:  P Rice; I Longden; A Bleasby
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

Review 2.  Mechanisms of antimicrobial peptide action and resistance.

Authors:  Michael R Yeaman; Nannette Y Yount
Journal:  Pharmacol Rev       Date:  2003-03       Impact factor: 25.468

3.  RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin.

Authors:  Jurgen Harder; Jens-Michael Schroder
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

4.  Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.

Authors:  Marc Torrent; Marina Badia; Mohammed Moussaoui; Daniel Sanchez; M Victòria Nogués; Ester Boix
Journal:  FEBS J       Date:  2010-02-23       Impact factor: 5.542

Review 5.  Antimicrobial peptides: successes, challenges and unanswered questions.

Authors:  William C Wimley; Kalina Hristova
Journal:  J Membr Biol       Date:  2011-01-12       Impact factor: 1.843

6.  Structure-activity relationships of an antimicrobial peptide plantaricin s from two-peptide class IIb bacteriocins.

Authors:  Wael Soliman; Liru Wang; Subir Bhattacharjee; Kamaljit Kaur
Journal:  J Med Chem       Date:  2011-03-09       Impact factor: 7.446

7.  Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract.

Authors:  John D Spencer; Andrew L Schwaderer; Julianne D Dirosario; Kirk M McHugh; Glen McGillivary; Sheryl S Justice; Ashley R Carpenter; Peter B Baker; Jürgen Harder; David S Hains
Journal:  Kidney Int       Date:  2011-04-27       Impact factor: 10.612

Review 8.  Staphylococcus saprophyticus as a common cause of urinary tract infections.

Authors:  B Hovelius; P A Mårdh
Journal:  Rev Infect Dis       Date:  1984 May-Jun

9.  Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics.

Authors:  Paulo F Almeida; Antje Pokorny
Journal:  Biochemistry       Date:  2009-09-01       Impact factor: 3.162

10.  RNase 7 contributes to the cutaneous defense against Enterococcus faecium.

Authors:  Bente Köten; Maren Simanski; Regine Gläser; Rainer Podschun; Jens-Michael Schröder; Jürgen Harder
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more
  19 in total

Review 1.  Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.

Authors:  Brian Becknell; Andrew Schwaderer; David S Hains; John David Spencer
Journal:  Nat Rev Nephrol       Date:  2015-07-07       Impact factor: 28.314

Review 2.  The therapeutic applications of antimicrobial peptides (AMPs): a patent review.

Authors:  Hee-Kyoung Kang; Cheolmin Kim; Chang Ho Seo; Yoonkyung Park
Journal:  J Microbiol       Date:  2016-12-30       Impact factor: 3.422

3.  Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract.

Authors:  Tad E Eichler; Brian Becknell; Robert S Easterling; Susan E Ingraham; Daniel M Cohen; Andrew L Schwaderer; David S Hains; Birong Li; Ariel Cohen; Jackie Metheny; Susheela Tridandapani; John David Spencer
Journal:  Kidney Int       Date:  2016-07-09       Impact factor: 10.612

4.  Carbonic anhydrase 2 deficiency leads to increased pyelonephritis susceptibility.

Authors:  David S Hains; Xi Chen; Vijay Saxena; Evan Barr-Beare; Weisi Flemming; Robert Easterling; Brian Becknell; George J Schwartz; Andrew L Schwaderer
Journal:  Am J Physiol Renal Physiol       Date:  2014-08-20

5.  Why are diabetics prone to kidney infections?

Authors:  Michael Zasloff
Journal:  J Clin Invest       Date:  2018-11-12       Impact factor: 14.808

6.  Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7.

Authors:  David Pulido; Marc Torrent; David Andreu; M Victoria Nogués; Ester Boix
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

Review 7.  The innate immune response during urinary tract infection and pyelonephritis.

Authors:  John David Spencer; Andrew L Schwaderer; Brian Becknell; Joshua Watson; David S Hains
Journal:  Pediatr Nephrol       Date:  2013-06-05       Impact factor: 3.714

8.  Expression and function of human ribonuclease 4 in the kidney and urinary tract.

Authors:  Kristin Bender; Laura L Schwartz; Ariel Cohen; Claudia Mosquera Vasquez; Matthew J Murtha; Tad Eichler; Jason P Thomas; Ashley Jackson; John David Spencer
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-05

9.  An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract.

Authors:  John D Spencer; Andrew L Schwaderer; Tad Eichler; Huanyu Wang; Jennifer Kline; Sheryl S Justice; Daniel M Cohen; David S Hains
Journal:  Kidney Int       Date:  2013-10-09       Impact factor: 10.612

10.  Human antimicrobial peptides and proteins.

Authors:  Guangshun Wang
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.